Jul 23, 2026 09:15AM
Jul 23, 2026 09:15AM
Jul 13, 2026 07:06AM
Jul 13, 2026 07:05AM
Jul 6, 2026 04:05PM
Jul 6, 2026 04:05PM
Jun 18, 2026 09:20AM Longeveron stem cell therapy data to be presented at 2026 AAIC
Jun 18, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 9, 2026 09:20AM
Jun 4, 2026 09:15AM
May 20, 2026 04:06PM
May 20, 2026 04:05PM
May 13, 2026 04:05PM Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
May 11, 2026 09:10AM
May 11, 2026 09:10AM
May 8, 2026 04:05PM
May 8, 2026 04:05PM
May 5, 2026 04:15PM
Apr 8, 2026 09:15AM
Mar 17, 2026 04:05PM Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
Mar 12, 2026 09:00AM
Mar 11, 2026 04:05PM
Mar 11, 2026 04:05PM
Mar 10, 2026 09:01AM
Mar 10, 2026 09:00AM
Feb 25, 2026 11:05AM
Feb 25, 2026 11:05AM Longeveron® Results of Phase 2b Clinical Trial Demonstrating Stem Cell Therapy Improved Condition of Patients with Age-Related Frailty Published in Cell Stem Cell
Feb 13, 2026 04:30PM
Feb 13, 2026 04:30PM
Feb 5, 2026 09:15AM
Jan 29, 2026 09:15AM
Jan 29, 2026 09:15AM
Jan 26, 2026 09:15AM
Jan 26, 2026 09:15AM Longeveron Announces FDA Grants Type C Meeting Ahead of Data Readout for Pivotal Phase 2 Clinical Trial (ELPIS II) Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
Dec 29, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 17, 2025 09:15AM
Dec 3, 2025 09:15AM
Dec 3, 2025 09:15AM
Dec 2, 2025 09:15AM
Dec 2, 2025 09:15AM Longeveron Granted Canadian Patent for Method of Using Stem Cells to Treat Non-Ischemic Dilated Cardiomyopathy and Aging-related Frailty in Patients with Inflammaging
Dec 1, 2025 12:02PM
Dec 1, 2025 12:00PM
Nov 19, 2025 09:15AM
Nov 19, 2025 09:15AM
Nov 12, 2025 09:05AM
Nov 12, 2025 09:05AM
Nov 4, 2025 04:05PM Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
Oct 28, 2025 09:15AM

326,872 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All